The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites by Dembele, L, Ang, X, Chavchich, M, Bonamy, GMC, Selva, JJ, Lim, MY, Bodenreider, C, Yeung, BKS, Nosten, F, Russell, BM, Edstein, MD, Straimer, J, Fidock, DA, Diagana, TT, Bifani, P

Comparative 3D genome organization in apicomplexan parasites by Bunnik, EM, Venkat, A, Shao, J, McGovern, KE, Batugedara, G, Worth, D, Prudhomme, J, Lapp, SA, Andolina, C, Ross, LS, Lawres, L, Brady, D, Sinnis, P, Nosten, F, Fidock, DA, Wilson, EH, Tewari, R, Galinski, MR, Mamoun, CB, Ay, F, Le Roch, KG

Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity by Vanaerschot, M, Lucantoni, L, Li, T, Combrinck, JM, Ruecker, A, Kumar, TRS, Rubiano, K, Ferreira, PE, Siciliano, G, Gulati, S, Henrich, PP, Ng, CL, Murithi, JM, Corey, VC, Duffy, S, Lieberman, OJ, Veiga, MI, Sinden, RE, Alano, P, Delves, MJ, Sim, K, Winzeler, EA, Egan, TJ, Hoffman, SL, Avery, VM, Fidock, DA

Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness by Stokes, BH, Dhingra, SK, Rubiano, K, Mok, S, Straimer, J, Gnädig, NF, Deni, I, Schindler, KA, Bath, JR, Ward, KE, Striepen, J, Yeo, T, Ross, LS, Legrand, E, Ariey, F, Cunningham, CH, Souleymane, IM, Gansané, A, Nzoumbou-Boko, R, Ndayikunda, C, Kabanywanyi, AM, Uwimana, A, Smith, SJ, Kolley, O, Ndounga, M, Warsame, M, Leang, R, Nosten, F, Anderson, TJ, Rosenthal, PJ, Ménard, D, Fidock, DA

Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. by Antonova-Koch, Y, Meister, S, Abraham, M, Luth, MR, Ottilie, S, Lukens, AK, Sakata-Kato, T, Vanaerschot, M, Owen, E, Rodriguez, JC, Maher, SP, Calla, J, Plouffe, D, Zhong, Y, Chen, K, Chaumeau, V, Conway, AJ, McNamara, CW, Ibanez, M, Gagaring, K, Serrano, FN, Eribez, K, Taggard, CM, Cheung, AL, Lincoln, C, Ambachew, B, Rouillier, M, Siegel, D, Nosten, F, Kyle, DE, Gamo, F-J, Zhou, Y, Llinás, M, Fidock, DA, Wirth, DF, Burrows, J, Campo, B, Winzeler, EA

Artemisinin resistance phenotypes and K13 inheritance in a Plasmodium falciparum cross and Aotus model by Sá, JM, Kaslow, SR, Krause, MA, Melendez-Muniz, VA, Salzman, RE, Kite, WA, Zhang, M, Moraes Barros, RR, Mu, J, Han, PK, Mershon, JP, Figan, CE, Caleon, RL, Rahman, RS, Gibson, TJ, Amaratunga, C, Nishiguchi, EP, Breglio, KF, Engels, TM, Velmurugan, S, Ricklefs, S, Straimer, J, Gnädig, NF, Deng, B, Liu, A, Diouf, A, Miura, K, Tullo, GS, Eastman, RT, Chakravarty, S, James, ER, Udenze, K, Li, S, Sturdevant, DE, Gwadz, RW, Porcella, SF, Long, CA, Fidock, DA, Thomas, ML, Fay, MP, Sim, BKL, Hoffman, SL, Adams, JH, Fairhurst, RM, Su, X-Z, Wellems, TE

UCT943, a next generation plasmodium falciparum PI4K inhibitor preclinical candidate for the treatment of malaria by Brunschwig, C, Lawrence, N, Taylor, D, Abay, E, Njoroge, M, Basarab, GS, Le Manach, C, Paquet, T, Cabrera, D, Nchinda, AT, de Kock, C, Wiesner, L, Denti, P, Waterson, D, Blasco, B, Leroy, D, Witty, MJ, Donini, C, Duffy, J, Wittlin, S, White, KL, Charman, SA, Jiménez-Díaz, MB, Angulo-Barturen, I, Herreros, E, Gamo, FJ, Rochford, R, Mancama, D, Coetzer, TL, van der Watt, ME, Reader, J, Birkholtz, L-M, Marsh, KC, Solapure, SM, Vanaerschot, M, Fidock, DA, Fish, PV, Siegl, P, Smith, DA, Wirjanata, G, Noviyanti, R, Price, RN, Marfurt, J, Silue, KD, Street, LJ, Chibale, K